While our study provides compelling evidence for the involvement of the ZFAS1/STAT3 axis in regulating IM resistance in CML cells through reprogramming of glucose metabolism, the findings are limited by the exclusive use of in vitro models. The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.